📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Micreos

1.1 - Company Overview

Micreos Logo

Micreos

Headquarter: The Netherlands
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of phage-based precision antimicrobials and engineered endolysins targeting pathogenic bacteria without harming the beneficial microbiome. Offerings include antimicrobial vectors; MEndoB for staphylococcal infections, including MRSA, for systemic/topical use; XZ.700 for S. aureus colonization in lesional skin (CTCL); and clinical/pre-clinical molecules for out-licensing, with focus areas including CTCL and AD.

Products and services

  • MEndoB: Precision-engineered antimicrobial targeting staphylococcal infections, including resistant strains like MRSA, suitable for systemic and topical use
  • XZ.700: Recombinant endolysin engineered to control Staphylococcus aureus colonization in lesional skin, demonstrating promise in treating Cutaneous T-cell Lymphoma
  • Antimicrobial Vectors: Phage-derived genetic scaffolds architected to create precision antimicrobials that treat bacterial infections without damaging the beneficial microbiome

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Micreos

Excelimmune Logo

Excelimmune

HQ: United States Website
  • Description: Provider of fully human recombinant polyclonal antibodies for therapeutics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Excelimmune company profile →
Genelabs Technologies Logo

Genelabs Technologies

HQ: United States Website
  • Description: Provider of biopharmaceutical R&D focused on discovering and developing therapies for infectious diseases, offering drug discovery services and medications including Morphine for severe pain, Atomoxetine (Strattera) for ADHD, Finasteride (Propecia) for male pattern hair loss, and Valacyclovir (Valtrex) for herpes and shingles.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Genelabs Technologies company profile →
Pharmasset Logo

Pharmasset

HQ: United States Website
  • Description: Provider of novel oral therapeutics to treat viral infections, with a primary focus on hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV). Clinical-stage pharmaceutical company committed to discovering, developing, and commercializing antiviral drugs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pharmasset company profile →
Rational Vaccines Logo

Rational Vaccines

HQ: United States Website
  • Description: Provider of pre-clinical live-attenuated herpes simplex virus vaccines.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rational Vaccines company profile →
Topica Pharmaceuticals Logo

Topica Pharmaceuticals

HQ: United States Website
  • Description: Provider of clinical research-stage topical treatments targeting fungal infections of the nail.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Topica Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Micreos

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Micreos

2.2 - Growth funds investing in similar companies to Micreos

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Micreos

4.2 - Public trading comparable groups for Micreos

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Micreos

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Micreos

What does Micreos do?

Micreos is a provider of phage-based precision antimicrobials and engineered endolysins targeting pathogenic bacteria without harming the beneficial microbiome. Offerings include antimicrobial vectors; MEndoB for staphylococcal infections, including MRSA, for systemic/topical use; XZ.700 for S. aureus colonization in lesional skin (CTCL); and clinical/pre-clinical molecules for out-licensing, with focus areas including CTCL and AD.

Who are Micreos's competitors?

Micreos's competitors and similar companies include Excelimmune, Genelabs Technologies, Pharmasset, Rational Vaccines, and Topica Pharmaceuticals.

Where is Micreos headquartered?

Micreos is headquartered in The Netherlands.

How many employees does Micreos have?

Micreos has 1,000 employees 🔒.

When was Micreos founded?

Micreos was founded in 2010 🔒.

What sector and industry vertical is Micreos in?

Micreos is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Micreos

Who are the top strategic acquirers in Micreos's sector and industry

Top strategic M&A buyers and acquirers in Micreos's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Micreos?

Top strategic M&A buyers groups and sectors for Micreos include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Micreos's sector and industry vertical

Which are the top PE firms investing in Micreos's sector and industry vertical?

Top PE firms investing in Micreos's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Micreos's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Micreos's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Micreos's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Micreos include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Micreos's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Micreos?

The key public trading comparables and valuation benchmarks for Micreos include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Micreos for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Micreos with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Micreos's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Micreos with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Micreos's' sector and industry vertical?

Access recent funding rounds and capital raises in Micreos's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Micreos

Launch login modal Launch register modal